$166.36+3.35 (+2.06%)
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States.
Tenet Healthcare Corporation in the Healthcare sector is trading at $166.36 with a market capitalization of $14.2B. Wall Street consensus targets $244.57 (21 analysts), implying a +47.0% move over the next 12 months. The stock is currently near its 52-week low of $146.60, remaining 16.4% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. Risk note: RSI 28 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services...
In recent days, Moody’s upgraded Tenet Healthcare Corporation’s Corporate Family Rating to Ba2 from Ba3 and shifted its outlook to stable, citing sustained deleveraging supported by strong EBITDA and debt reduction over the past two years. This marks a meaningful external validation of Tenet’s balance sheet progress, particularly its emphasis on expanding ambulatory care while keeping financial policies disciplined. We’ll now examine how Moody’s credit upgrade, underpinned by Tenet’s...
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the legendary stocks that return 100 times your money.
Tenet Healthcare (THC) closed the most recent trading day at $161.37, moving 2.11% from the previous trading session.
Tenet (THC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Despite HCA Healthcare’s underperformance relative to the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.